Revolution Medicines, Inc.
USD188.32
-4.30 (-2.23%)
CEO
Mark A. Goldsmith
IPO Date
2020-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$190.42
Prev. Close
$192.62
Day Low
$187.70
Day High
$192.52
52W Low
$34.00
52W High
$193.09
Market Cap
$40.04B
Volume
1.42M
| -12.2 |
| 31 Dec 2023 | FY | 100.0% | -3768.3% | -23.9% | -21.2% | 0.05 | 13.06 | -7.4 |
| 31 Dec 2022 | FY | 100.0% | -703.0% | -36.3% | -30.6% | 0.09 | 10.65 | -7.7 |
| 31 Dec 2021 | FY | 100.0% | -636.6% | -31.0% | -25.4% | 0.11 | 9.77 | -9.8 |
| 31 Dec 2020 | FY | 100.0% | -251.6% | -22.8% | -19.1% | 0.07 | 9.63 | -24.4 |
| 31 Dec 2019 | FY | 100.0% | -95.2% | -31.2% | -21.6% | 0.00 | 3.11 | -22.1 |
| 31 Dec 2018 | FY | 100.0% | -207.2% | -43.2% | -24.5% | 0.00 | 2.80 | -25.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -687.0% | -206.5% | 0.00 | 1.24 | -33.9 |
| -10.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -19.1% | -13.6% | 0.10 | 8.05 | -7.2 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -13.3% | -10.2% | 0.07 | 11.79 | -7.0 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -10.3% | -9.0% | 0.06 | 13.46 | -7.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -8.6% | -7.6% | 0.06 | 14.20 | -9.4 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -10.0% | -8.9% | 0.06 | 14.24 | -12.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -8.2% | -7.4% | 0.05 | 15.42 | -12.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -6.7% | -6.1% | 0.05 | 18.45 | -11.2 |
| 31 Dec 2023 | Q4 | 100.0% | -21770.5% | -8.8% | -7.8% | 0.05 | 13.06 | -6.3 |